• Bioactive Molecules • Building Blocks • Intermediates www.ChemScene.com Anti-Cancer Compound Library (96-well) Product Details: Catalog Number: CS-L025 Formulation: A collection of 4779 anti-cancer compounds supplied as pre-dissolved Solutions or Solid Container: 96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode Storage: -80°C Shipping: Blue ice Packaging: Inert gas Plate layout: CS-L025-1 1 2 3 4 5 6 7 8 9 10 11 12 SKF-96365 Fumarate MRT68921 a Empty (hydrochlorid ML162 ML-210 hydratase-IN- (dihydrochlori Peretinoin SR-3029 CBR-5884 Mivebresib AZD0156 Empty e) 1 de) HLCL-61 b Empty BAY-876 BAY1125976 BAY-1436032 Tomivosertib LY3177833 (hydrochlorid PQR620 AT-130 NSC 663284 MK-4101 Empty e) Flavopiridol c Empty Flavopiridol (Hydrochlorid SNS-032 Ko 143 KNK437 TA-02 Mitoquinone AZD-5438 R547 4-IBP Empty e) (mesylate) d Empty SAR-020106 HUHS015 SMER28 A-196 TPEN CP21R7 HC-067047 EAI045 RSL3 GSK6853 Empty IQ-1S (free Rho-Kinase- e Empty CZ415 SANT-1 ME0328 acid) GSK591 Madrasin SZL P1-41 IN-1 Nutlin-3a 9-amino-CPT Empty MELK-8a f Empty GNE-495 EPI-001 CA-074 BI-7273 BI-9564 CL-82198 MS049 Remetinostat (hydrochlorid MRK-016 Empty methyl ester e) SHP099 g Empty Nigericin BH3I-1 SHP099 (hydrochlorid (S)- NVP- F16 PF-04979064 Nevanimibe CFMTI Empty (sodium salt) e) ML753286 BAW2881 hydrochloride h Empty Ro 67-7476 GNF-6231 PHCCC FCCP Linaprazan UKI-1 BFH772 CPI-455 KDM5-IN-1 CAN508 Empty Plate layout: CS-L025-2 1 2 3 4 5 6 7 8 9 10 11 12 αvβ1 integrin- TM5275 a Empty CCF642 IMR-1 IMR-1A PACMA 31 PD-161570 HA15 WYE-132 IN-1 (TFA) (sodium) AEE788 Empty REV7/REV3L b Empty TCS-OX2-29 HO-3867 Plerixafor TPI-1 -IN-1 NSC781406 ZYZ-488 CPI-637 A-804598 TAK-243 Empty Rilmenidine c Empty Bay 59-3074 TBHQ (hemifumarat Rilmenidine Fisogatinib BP-1-102 SH5-07 GSK2256098 Tyrphostin M2698 Empty e) (phosphate) AG 528 GSK484 d Empty CID5721353 GLPG0187 Avadomide ITSA-1 NPS-1034 RAF709 (hydrochlorid NVS-PAK1-1 Aprepitant GKI-1 Empty e) e Empty FMK 9a ML385 LRE1 XMU-MP-1 PD150606 CD437 DTP3 DTP3 (TFA) Golgicide A INH6 Empty D-α- GSK-LSD1 Cyclo(RGDyK f Empty Hydroxyglutar FLLL32 (dihydrochlori GSK621 (S)-Crizotinib Tie2 kinase SecinH3 Tempol ) SGC2085 Empty ic acid de) inhibitor 1 (trifluoroaceta Cl-amidine g Empty Necrosulfona (hydrochlorid Acriflavine NH125 AGK2 Ferrostatin-1 (-)-(S)-Equol (±)-Equol Splitomicin SirReal2 Empty mide e) Sodium h Empty Nicaraven stibogluconat Urolithin A HJC0152 BMS453 CaCCinh-A01 AS1517499 BVT948 WNK463 APS-2-79 Empty e hydrochloride Plate layout: CS-L025-3 1 2 3 4 5 6 7 8 9 10 11 12 Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA Tel: 732-484-9848 Fax: 888-484-5008 Email: [email protected] • Bioactive Molecules • Building Blocks • Intermediates www.ChemScene.com AZD5153 (6- Empty Ticagrelor Axitinib Hydroxy-2- Mycro 3 Y-33075 L002 JTE-013 CGS 15943 GSK2837808 MS-444 Empty a naphthoic A Y-33075 b Empty ML390 Propyl (dihydrochlori Lin28-let-7a SYP-5 TPOP146 NSC632839 Y-27632 Eganelisib GNE-272 Empty pyrazole triol de) antagonist 1 Histone c Empty GSK9311 Cambinol Acetyltransfer ML348 ML349 RA190 TPCA-1 S63845 GNE-140 (R)-GNE-140 Empty ase Inhibitor II (racemate) d Empty (S)-GNE-140 STF-62247 PSB-12379 CXD101 STAT3-IN-1 FUBP1-IN-1 Toxoflavin HTHQ CHS-828 Ciliobrevin A Empty NSC23005 Teglarinad e Empty (sodium) URB602 (chloride) Futibatinib 3-AP BGP-15 NCB-0846 UNC3866 GS-444217 JQEZ5 Empty TAK-659 f Empty IWP-O1 BRCA1-IN-2 (hydrochlorid Navitoclax WT-161 KRIBB11 Bisantrene GGTI298 GCN2-IN-1 Zibotentan Empty e) W-7 g Empty Acelarin BAY1082439 Simurosertib MX69 SAR-20347 OGT 2115 ML364 (hydrochlorid ML-9 MY-5445 Empty e) ATM-3507 h Empty CCCP CEP-40783 (trihydrochlori Beaucage (E)-AG 99 HA-100 10074-G5 Nrf2-IN-1 CCT251236 GSK 4027 Empty de) reagent Plate layout: CS-L025-4 1 2 3 4 5 6 7 8 9 10 11 12 ZK756326 a Empty GSK4028 ZINC1346675 LOM612 Sarcosine (dihydrochlori AG-494 D-erythro- Src Inhibitor 1 Kinetin TOFA Empty 1 de) Sphingosine riboside Acetylcholine b Empty Monastrol Salermide LY294002 NSC 228155 SKL2001 (iodide) CeMMEC13 RHPS4 AS-605240 KYA1797K Empty (2- Empty Importazole PD-1-IN-17 IC-87114 Hydroxypropy AR7 TG100-115 PF-06840003 EED226 666-15 TP-3654 Empty c l)-β- PI-103 Naltrindole d Empty PNU-74654 TGX-221 PGMI-004A SF2523 PI-103 (Hydrochlorid 2- (hydrochlorid Tesmilifene Ecteinascidin Empty e) Iodomelatonin e) (fumarate) 770 Tin- e Empty protoporphyri Silodosin Agmatine XMD16-5 ZINC0088152 RPI-1 L-732138 ODQ YKL-5-124 YKL-5-124 Empty n IX (sulfate) 4 (TFA) Milademetan f Empty Barasertib- (tosylate CHMFL-BMX- Barasertib STK16-IN-1 GDC-0326 EMT inhibitor- Thiomyristoyl ZM-447439 DMU2105 Empty HQPA hydrate) 078 1 Veliparib 3- g Empty DMU2139 Veliparib Iberdomide Pan-RAS-IN- PD-166866 (dihydrochlori R-IMPP Hesperin Harmane (Methylthio)pr Empty 1 de) opionic acid N-(5- SI-2 h Empty Aminopentyl) L-DABA RG14620 RG13022 Trolox (R)-Trolox (hydrochlorid PF-6274484 PBIT Ceefourin 1 Empty acetamide e) Plate layout: CS-L025-5 1 2 3 4 5 6 7 8 9 10 11 12 IT1t Trilaciclib a Empty SR0987 (dihydrochlori RAD51 (hydrochlorid (±)- Zanubrutinib Dihydromund LF3 GZD856 LY3214996 Empty de) Inhibitor B02 e) Zanubrutinib uletone (formic) MT-DADMe- Polyoxyethyle b Empty ImmA Pico145 F1063-0967 A-395 eIF4A3-IN-1 Cdc7-IN-1 TC13172 ne stearate AZD-5991 MRX-2843 Empty Elimusertib c Empty HI-TOPK-032 Linrodostat Avapritinib GDC-0077 GSK3326595 JNJ- Elimusertib (hydrochlorid BMS-986158 Roblitinib Empty 64619178 e) Nilotinib Empty Darovasertib Bosutinib Nilotinib NVX-207 (monohydroc Tozasertib MSC2530818 Olaparib Recilisib Ilaprazole Empty d hloride UAMC00039 e Empty LTURM34 Oxyphenisati IMD-0354 TM5441 PRN1371 (dihydrochlori BTB-1 CSF1R-IN-1 ML311 PHA-680632 Empty n acetate de) ZM223 Dasatinib f Empty EDO-S101 eIF4A3-IN-2 Danusertib (hydrochlorid NCGC002445 MLN8054 SK1-IN-1 Dasatinib (hydrochlorid CHIR-99021 Empty e) 36 e) CHIR-99021 CHIR-99021 EIPA g Empty (monohydroc (trihydrochlori DKM 2-93 dBET1 EIPA (hydrochlorid ML-18 FITM AX-15836 Fasentin Empty hloride) de) e) N6-(2- LYN-1604 h Empty STAT5-IN-1 Phenylethyl)a TG 100801 AU1235 Linsitinib Heparan NVP-TAE 684 Autophinib (dihydrochlori CM-272 Empty denosine Sulfate de) Plate layout: CS-L025-6 Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA Tel: 732-484-9848 Fax: 888-484-5008 Email: [email protected] • Bioactive Molecules • Building Blocks • Intermediates www.ChemScene.com 1 2 3 4 5 6 7 8 9 10 11 12 Sepantronium a Empty KDM4D-IN-1 CU-CPT17e AZD-1480 hVEGF-IN-1 TNP-470 (bromide) BTK IN-1 LY 345899 SMI-16a AD80 Empty CB-1158 IACS-9571 b Empty SPI-112 NCT-503 Wortmannin AZ PFKFB3 Selitrectinib CPI-444 (dihydrochlori AZD4635 BMS-754807 (hydrochlorid Empty 26 de) e) Tandutinib c Empty Rucaparib Sorafenib BMS-1166 6-Biopterin Sorafenib Tandutinib A2A receptor FX1 KY1220 (hydrochlorid Empty (Camsylate) (Tosylate) antagonist 1 e) KDOAM-25 d Empty Linperlisib Oxamflatin CDK9-IN-8 OSI-930 (citrate) STAT5-IN-2 Cediranib WM-1119 MOZ-IN-2 Amuvatinib Empty Retaspimycin e Empty WM-8014 Dovitinib Pazopanib SAFit2 2OH-BNPP1 JPM-OEt Masitinib Masitinib (Hydrochlorid Tanespimycin Empty (lactate) (mesylate) e) f Empty BIIB021 Luminespib Everolimus Rapamycin Vorinostat Ixabepilone CUDC-101 Panobinostat Belinostat Bortezomib Empty Motesanib BRAF AKT Kinase NVP- g Empty Motesanib (Diphosphate) Midostaurin Saracatinib inhibitor RAF265 GSK-690693 Inhibitor ADW742 AG1024 Empty SB 203580 h Empty PD0325901 Sunitinib SB 203580 (hydrochlorid BAY 11-7085 Vandetanib Afatinib Afatinib BMS-536924 SB 202190 Empty e) (dimaleate) Plate layout: CS-L025-7 1 2 3 4 5 6 7 8 9 10 11 12 (+)-BAY- (±)-BAY- (-)-BAY- a Empty Omipalisib GSK-923295 HSF1A HMN-154 Gusacitinib 1251152 1251152 1251152 BAY-1816032 LY3200882 Empty BET EHNA b Empty Repotrectinib PIK-294 bromodomain Diethyl- T-3775440 E7046 R162 PU02 inS3-54A18 (hydrochlorid Empty inhibitor pythiDC hydrochloride e) 5'-N- Empty Ethylcarboxa Proxalutamid Doramapimod PD173074 Falnidamol D4476 Ro 90-7501 TCPOBOP Toyocamycin CL-387785 Empty c midoadenosin e Regorafenib d Empty TC ASK 10 GW788388 BAI1 PD176252 JNJ-7706621 Toceranib Toceranib Regorafenib Calmidazoliu (monohydrate Empty (phosphate) m chloride ) 1- e Empty BMS-690514 PETCM CA-074 Proglumide Brivanib Brivanib Foretinib Aminobenzotr KW-2449 Methylmaloni Empty (sodium) (alaninate) iazole c acid Tirbanibulin Fasudil f Empty Tirbanibulin (dihydrochlori Tirbanibulin (Hydrochlorid Enzastaurin Sotrastaurin AZD 6482 ARP-100 G15 PHTPP Empty de) (Mesylate) e) 5'- MK-2206 g Empty AV-412 Fluoroindirubi AV-412 (free JNJ0966 PI-273 Takinib AKT inhibitor (dihydrochlori DUPA(OtBu)- LCL521 Empty noxime base) VIII de) OH LCL521 4,4'- PROTAC PROTAC Amifostine (2R)-Octyl-α- (2S)-Octyl-α- h Empty dihydrochlorid Dimethoxybe PKM2-IN-1 CDK9 BET thiol hydroxyglutar hydroxyglutar GW779439X K00546 Empty e nzil Degrader-1 Degrader-1 (dihydrochlori ate ate Plate layout: CS-L025-8 1 2 3 4 5 6 7 8 9 10 11 12 Fmoc-1,6- IPN60090 Canertinib a Empty Tetraphenylp BI-78D3 MAK683 diaminohexan STING 2-HBA Canertinib IPN60090 (dihydrochlori (dihydrochlori Empty orphyrin e agonist-3 de) de) Samuraciclib b Empty PF-06726304 NAZ2329 CD73-IN-1 PTC-028 Gardiquimod iCRT3 ROC-325 Pim1/AKK1- IBR2 (hydrochlorid Empty (diTFA) IN-1 e) Samuraciclib c Empty (trihydrochlori Seclidemstat Ensartinib PP121 Semaxinib PD173955 Emricasan CTS-1027 BAY-320 BAY-524 Empty de) hydrochloride Fmoc-Ser(O- Empty α-D- Asciminib NecroX-5 Losmapimod L-Kynurenine PH-797804 IDH-305 Cintirorgon MKC8866 Vorasidenib Empty d GalNAc(OAc) Naphthol AS- e Empty Pamiparib QC6352 Lanifibranor